Dawson James Starts Synergetics USA (SURG) at Buy; SURG-ing ahead
Tweet Send to a FriendGet Alerts SURG Hot Sheet
Price: $3.70 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade SURG Now!
Dawson James initiates coverage on Synergetics USA (NASDAQ: SURG) with a Buy. PT $6.25.
Dawson analyst says, "Since new top management took over at Synergetics USA two years ago, the Company has bolstered its balance sheet, settled pending patent litigation favorably, streamlined manufacturing processes and product lines, increased revenues, net income, and gross margins, and certainly caught the eye of the investment public. Still, perhaps due to its smaller size or the relative newness of its management team, Synergetics’ shares continue to trade at a discount to its industry peers based on several valuation metrics, and we feel that as the Company and its stock become more well known and as the Company continues to advance its growth strategies, the shares will continue to appreciate."
For more ratings news on Synergetics USA click here and for the rating history of Synergetics USA click here.
Shares of Synergetics USA closed at $4.60 yesterday, with a 52 week range of $1.15-$5.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Dawson analyst says, "Since new top management took over at Synergetics USA two years ago, the Company has bolstered its balance sheet, settled pending patent litigation favorably, streamlined manufacturing processes and product lines, increased revenues, net income, and gross margins, and certainly caught the eye of the investment public. Still, perhaps due to its smaller size or the relative newness of its management team, Synergetics’ shares continue to trade at a discount to its industry peers based on several valuation metrics, and we feel that as the Company and its stock become more well known and as the Company continues to advance its growth strategies, the shares will continue to appreciate."
For more ratings news on Synergetics USA click here and for the rating history of Synergetics USA click here.
Shares of Synergetics USA closed at $4.60 yesterday, with a 52 week range of $1.15-$5.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wedbush Starts Owens Corning (OC) at Outperform
- Maxim Group Starts Agenus (AGEN) at Buy, PT $19
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
